fore, be vulnerable to further injury by agents with potential to both injure tissues and deleteriously influence healing. In addition, the wide array of invasive therapeutic and monitoring interventions, together with those features inherent to an intensive care setting, may combine to create a potentially hostile healing environment.
This article provides an overview of the generally accepted processes involved in skin and skeletal muscle wound healing and then discusses the potential influences of critical illness and intensive care on those processes.
Biology of Wound Healing
Wound healing generally involves the initiation and integration of a biological response, coordinating the migration, proliferation, and differentiation of a heterogeneous group of cells to achieve restoration of tissue stability, continuity, and function. In humans, hepatic and epithelial tissue are capable of regeneration after injury. The depth of a cutaneous injury will influence the process of healing, as disruption of the basement membrane and deeper dermal tissue dictates that epidermal cells migrate over a provisional matrix and not an intact membrane, dissecting between viable and nonviable tissues in the process (3) .
Generally, in soft tissue injury, progress toward healing follows a complex series of events, characterized by these four main phases: Hemostasis Inflammation Proliferation Scar maturation
In the nonhealing wound, this sequence of events is arrested at one or more phases and may develop a "progression-regression" or "seesaw" pattern of healing.
Hemostasis. The first phase of healing occurs immediately after the injury. In the first 24 hrs, this commences as the formation of the hemostatic primary platelet plug stimulated by thrombin and exposed fibrillar collagens and the influx of neutrophils from the blood. Hemostasis is further achieved by vasospasm, which reduces the blood vessel diameter and thus blood loss. The platelet plug generally fills the tissue deficit left by the injury. The clotting cascade is activated via several local factors released in the area of tissue injury, including stimulated platelets adhering to the site. The end result of the activated intrinsic and extrinsic pathways is the conversion of fibrinogen to fibrin by thrombin, which is further modified to create a stable thrombus (4) . Blood coagulation also stimulates complement activation (5) . Fibronectin, a cell adhesion molecule found in many tissues, is incorporated into the clot framework, and hyaluronic acid, a member of the glycosaminoglycan family that is present in most tissues, adheres to the fibrin and fibronectin components. Activated platelets are the first cells to release large amounts of cytokines involved in hemostasis and inflammation, affecting chemotaxis and angiogenesis, altering cellular expression, and increasing vascular permeability, thus facilitating leukocyte diapedesis into the wound site. These include platelet derived growth factor, transforming growth factor-␤1, 5-hydroxytryptamine, and adenosine diphosphate.
Inflammation-The Influx of Inflammatory Cells. The migration of cells into the clot represents the inflammatory phase, which is further subdivided into early and late phases. The early phase is characterized by the influx of neutrophils, whose main function is to cleanse the wound of foreign material. After 24 hrs, the macrophage becomes the predominant cell and this represents the late inflammatory phase. These cells are derived from circulating monocytes attracted to the site of injury by chemotactic agents released in association with activated platelets, a process influenced by steroid administration (6). They continue the process of wound debris degradation and microorganism ingestion and persist in the wound site, orchestrating the process of healing by secreting soluble growth factors and cytokines, including tumor necrosis factor-␣, interleukins (including interleukin-6), platelet derived growth factor, transforming growth factor-␤, insulin-like growth factors, and enzymes involved with nitric oxide (NO) production. A reduction in vascular perfusion and a switching of cells to anaerobic metabolic pathways and metabolites released by macrophages as a consequence of their activities create wound bed environments that are hypoxic (PO 2 0 -15 mm Hg), acidotic (pH 6.5-7.2), and hypoglycemic (2-4 mmol/L), with elevated lactic acid concentrations (7). Macrophages secrete an array of proinflammatory agents (8) . Mature macrophages secrete a number of matrix metalloproteinases (MMPs) although less than those produced by fibroblasts (9) . MMPs are believed to aid in the regulation of collagen deposition (10) .
NO is believed to play an important role in wound healing, affecting vascular reactivity, macrophages, and collagen production by fibroblasts (11) . Skin keratinocytes at wound margins also express NO. NO is a reactive oxygen species synthesized from L-arginine under the influence of NO synthase. It has been proposed that NO is involved in many aspects of wound healing (12) . Metallothioneins are low molecular weight proteins, activated following skin injury and thought to be involved in mitotic regulation, scavenging for toxic radicals, and modulation of gaseous mediators including NO; they also may influence inflammation. Induction of these agents by zinc, copper, and other metals such as silver may promote cell proliferation and re-epithelialization (13) . Excessive wound contamination can disrupt the normal healing by causing neutrophils to remain in high numbers within the wound and prolong the inflammatory response phase with potential to cause further tissue injury by reactive oxygen species (ROS) production.
Lymphocytes. This diverse group of monocytes also accumulate at the wound, but in lower numbers than macrophages. Their exact role is unclear, but they may influence cellular regulation and so modulate wound healing (14) . Manipulation of T-cell lymphocyte activity influences wound healing, but research into its role in human skin healing is limited (15) . B lymphocytes appear to have no role in wound healing (16, 17) .
Proliferative Phase
Fibroplasia. The increase in fibroblast wound numbers and the matrix they produce coincide with the formation of granulation tissue. They arise from both in situ cell proliferation and migration from adjacent areas (18) . Their function is to synthesize structural proteins, reorganize the wound matrix, and promote wound contraction. In addition to collagen, they produce tenascin, fibronectin, and glycosaminoglycans. Hypoxia has been demonstrated to increase in vitro fibroblast activity (19) . Migration of fibroblasts is afforded by contact guidance along extracellular matrix fibrils and haptotaxis via adhesion molecules, stimulated by a wide range of chemotactic agents including matrix fragments and cytokines (20, 21) .
Extracellular Matrix Formation. The matrix laid down by activated fibroblasts facilitates the migration of macrophages and fibroblasts and guides new capillaries in a scaffold network. The fibroblasts also restructure the matrix as healing progresses. Granulation tissue formation follows a sequence of events in acute wounds: the deposition of fibronectin and hyaluronic acid, followed by collagen type III and then type I (22) . Fibronectin provides a scaffold for collagen deposition and influences cellular activity in early wound remodeling (23). The polysaccharide hyaluronic acid is synthesized at the cell membrane and extruded directly into the extracellular matrix. Its role is unclear, but it may participate in creating a network facilitating cell migration (24) . Hyaluronic acid exerts a high osmotic pressure, creating a highly porous network into which inflammatory cells can migrate. Tissue injury causes this polymer to depolymerize into smaller fragments, the reasons for which are unclear (25) . However, degradation products of this molecule have been identified as angiogenic stimulators and may protect tissue from ROS injury (26, 27) . Levels of hyaluronic acid decline as the wound matures, as levels of extracellular matrix proteoglycans, such as chondroitin-4-sulfate and dermatan sulfate, correspondingly increase.
Collagen. This group of triple helix glycoproteins form superhelical structures found in the extracellular matrix. Many types have been identified, of which three classes are important in the formation of new connective tissue. Types I, II, III, and V are fibrillar, type IV is found in basement membranes, and the remainder are interstitial collagens. Collagens are secreted by fibroblasts as procollagens, which are further modified and then aggregated to form fibrils. Type I collagen is a major constituent found in fibrous connective tissue. Types I and III are found early in healing wounds (28) . Fibroblasts also produce elastin and laminin.
Fibroblasts differentiate into myofibroblasts by development of cytoskeletal protein expression that includes actin, myosin heavy chain, and MyoD (29) . This affords these cells contractile properties that enable the cells to promote wound edge contraction (30) . These cells further remodel the extracellular matrix. The remodeling of the collagen-rich matrix is particularly active at the contracting wound margins, as existing matrix is degraded by several enzyme systems, including MMPs and plasminogen activators, and new matrix is deposited as wound contraction progresses (31) . This process continues through the remodeling phase. An imbalance of matrix synthesis and its degradation by MMPs is implicated in delayed healing (32) .
Neovascularization. Angiogenesis requires the stimulation of endothelial cell mitogenesis and migration. Fragmentation of the venular basement membrane facilitates the migration and proliferation of these cells at an early stage in wound healing, simultaneously entering the wound with inflammatory cells and fibroblasts (33) . Further endothelial cell migration is orchestrated to form tubules which, via branches, connect and form loops and plexuses, involving surface integrins. This process is dependent on continued collagen production (34) . Many aspects of the wound environment potentially influence angiogenesis. Hypoxia and increased lactate concentrations in early wound healing stimulate the release of macrophage-derived angiogenic agents, and hypoxia has profound effects on endothelial cells via several hypoxiainducible factors, which appear to affect gene transcription and the production of vascular endothelial growth factor (35, 36) .
Granulation Tissue Formation. The formation of a granular, highly vascular, red tissue in a wound soon after injury visually represents the proliferative phase in the normal healing response. This tissue consists of inflammatory cells, fibroblasts, and neovasculature in a loose matrix of collagen, fibronectin, and hyaluronic acid. This wound environment facilitates the recruitment of inflammatory cells, fibroblasts, and endothelial cells essential for tissue repair.
Skin Re-Epithelialization and Maturation
When epithelial continuity is disrupted, a cover of protein exudate composed mainly of fibrin and serum protects the wound. Restoration of the epithelium occurs from the wound edge by keratinocyte hyperplasia immediately adjacent to the wound edge and migration of a subset of keratinocytes, which have phagocytic activity and secrete proteases (37, 38) .
Keratinocyte migration over the provisional matrix, facilitated by fibronectin synthesis and ␤1-integrins, is followed by formation of a new basement membrane and progresses into the regenerative phase with formation of a mature stratum corneum, the outermost epidermal layer (39, 40) . Remodeling of the resultant scar then progresses over months or years, with a reduction of its cellular content and vascularity.
Muscle Regeneration and Fibrosis
The response of muscle to injury follows a similar course to that of cutaneous healing. There is an initial phase of clot formation and inflammation following muscle disruption, but, in addition, there is an associated degeneration of injured myofibers, usually resulting in fibrosis. Regeneration may occur if the basement membrane and endomysium remain intact. The influx of inflammatory cells into the site of injury represents the inflammatory stage. A particular feature of the extracellular matrix is the presence of tenascin-C, a protein associated with tissues exposed to high mechanical forces (41) . It is generally accepted that a population of satellite cells, situated between the basal lamina and plasma membrane, which have stem cell-like characteristics, are locally activated by myofiber degeneration. Macrophages expressing the allograft inflammatory factor-1 have been demonstrated to play an important role in many aspects of satellite cell activity (42) . Under the influence of growth factors released by inflammatory cells, they proliferate and differentiate into myoblasts, which further differentiate and fuse forming myotubes and subsequently myofibers, thus promoting muscle regeneration (43) . More recent studies have suggested that myogenic cells can be derived from stem cells in bone marrow, connective tissues, and postmitotic nuclei of muscle fibers, although their participation in healing is likely to be small (44) . Activated satellite cells also may be involved in tissue remodeling via gene activation, coding for signaling molecules (45) . Complete regeneration of muscle fibers is dependent on reinnervation by new nerve terminals. Fibroblasts produce predominantly type III collagen immediately postinjury, type I collagen reestablishing dominance later in the repair process (46) . Fibrosis is the dominant feature of the healing process, particularly when the tissue deficit is larger, with only a limited amount of muscle regeneration (47) .
Factors Influencing Soft Tissue Wound Healing in Critical Illness
Critically ill patients are potentially more prone to soft tissue wound complications than other individuals for two main reasons:
The increased number of soft tissue wounds, either due to accidental trauma or created by healthcare workers in the interests of the patient, particularly in an intensive care setting The presence of many potential causes of delayed healing, prolonging the exposure of tissue unprotected by an intact epithelium and increasing the likelihood of complications ( Fig. 1) Even in the nontrauma/burn patient, the requirement for intravenous and intra-arterial access in critically ill patients in an intensive care setting and the frequent creation of surgical wounds mean that skin and muscle injury is commonplace.
The cause of a critical illness and the therapeutic interventions it attracts will of course influence how wound healing is affected. The effects of specific system failures on soft tissue healing will be presented, but it should be recognized that many dysfunctional influences may be present at any one time, their interactions making their effects on wound healing even more complex (Fig. 2) . Despite the varied causes of critical illness, however, they share certain features that may influence soft tissue wound healing. These features include inadequate tissue perfusion, altered immune status, deleterious metabolism, poor nutritional status, and local factors such as wound infection and contamination with foreign material.
The patient may already have characteristics that predispose him or her to soft tissue wound healing dysfunction before the onset of critical illness. This has been studied in surgical patents in an attempt to predict wound complications in abdominal and breast reconstructive surgery (48 -50) . They include obesity, cardiovascular disease affecting tissue perfusion, respiratory disease affecting adequate blood oxygenation, metabolic disease, endocrine disease, and renal and hepatic failure. Diabetes mellitus affects soft tissue healing via metabolic, vascular, and neuropathic pathways, as typified in diabetic foot disease (51) . Increasing age is associated with delayed healing, but it is difficult to separate the effects of age alone from those diseases commonly associated with age (52). Supplementation using topical estrogen has been demonstrated to improve healing in elderly females (53) .
Malignancy and its treatments can have profound effects on the ability of an individual to mount a response to injury and infection. Poor nutrition, specific organ compromise, ectopic hormone production, and immune and hematological effects together with aggressive therapies including potent antimetabolic, cytotoxic, and steroidal agents and radiation are all associated with compromised immunity, increased susceptibility to sepsis, and failure of tissue repair (54 -56) .
The stresses associated with critical illness may further significantly affect healing. Critical illness places higher demands on tissue oxygen supply due to the stresses of acute illness and the requirements of an increased cellular activity associated with wound healing. Changes in the transport and exchange of oxygen associated with critical illness, particularly in the peripheral tissues, must be remembered so that sufficient oxygen is delivered and tissue hypoxia avoided (57) .
The edema and locally raised pressures associated with ischemic tissue injury can potentially further compromise perfusion. The inflammatory response to wounding may be prolonged as a result, thus delaying healing. This is dramatically demonstrated in the development of compartment-syndrome in limb skeletal muscles following ischemia and reperfusion. Mast cells in skeletal muscle have been demonstrated to produce most of the NO associated with ischemia-reperfusion injury (58) .
Tissue Hypoxia. Healing is an energydependent process relying on a ready supply of energy-rich molecules in the form of adenosine triphosphate (ATP). The initial anaerobic conditions following injury stimulate cells to adopt anaerobic production of ATP via glycolysis (7). In contrast, the proliferative phase of healing with its increased metabolism and protein synthesis requires much larger quantities of ATP via oxidative phosphorylation. This demands a rich blood supply to provide glucose and oxygen. Hypoxia or reduced provision of glucose therefore has the potential to disrupt the healing process (59) .
The physiologic response of the vascular endothelium to localized hypoxia in the early phase of wound healing is to precipitate vasodilation and stimulate fibrin deposition, proinflammatory activity, capillary leak, and neovascularization. However, the endothelial response to sustained or severe stresses such as reperfusion injury or hypoxia has been demonstrated to be impaired due to a reduction in endothelial cell viability (60) .
Wound neutrophil activity has been demonstrated to be impaired at lower oxygen tensions identified in wounds. Low temperature, low pH, and elevated glucose concentrations also limit leukocyte function (61) . Dermal fibroblast gene expression for angiogenesis has been demonstrated to be up-regulated in a timedependent fashion by hypoxia for a period of 24 hrs but then down-regulates if hypoxic conditions persist. It is proposed that angiogenesis itself would oxygenate the wound after 24 hrs. Type 1 ␣1 collagen was abruptly down-regulated at 48 hrs in hypoxic conditions, thus disrupting collagen synthesis. This suggests that fibroblasts exposed to longer periods of hypoxia may not participate in the formation of the extracellular matrix, thus delaying healing (62) . Hypoxia for Ͼ24 hrs and up to 72 hrs has been demonstrated to induced gene activation of MMP-1 in human dermal fibroblasts. This effect of prolonged hypoxia may enhance matrix degradation and further delay healing in soft tissues (63) .
Tissue Perfusion. The disruption of tissue perfusion, be it acute or chronic, can be categorized as local or general.
Generalized peripheral hypoperfusion due to decreases in circulatory volumes, cardiac insufficiency, inotropic infusions, or large vessel disruption Local hypoperfusion due to small vessel occlusion secondary to emboli, vasculitis, arterial and venous thrombosis, or locally raised tissue pressures due to extrinsic (e.g., focal external pressure for prolonged periods) or intrinsic factors (e.g., hematoma or extravasation of chemical agents or hypertonic solutions into perivascular tissues, causing acute swelling and an acute inflammatory response)
Hypovolemia. Skin and skeletal muscle are highly vascular tissues. Their vascularity facilitates rapid repair and regeneration so that function can be restored quickly after injury. A response to body fluid losses is to reduce the circulating blood volume distributed to the skin and soft tissues. The skeletal muscle and, in particular, the cutaneous circulations are particularly adaptive and responsive. This feature is manipulated via circulating and neural adrenergic mechanisms to maintain physiologic stability and protect vital organs (64) . This same feature also renders these tissues vulnerable to pathologic hypoperfusion and ischemia particularly when associated with tissue edema.
Hypothermia and Pain. Hypothermia also has a profound effect on cutaneous perfusion by inducing peripheral vasoconstriction. The thermal insulation of wounds is therefore important, particularly so in those critically ill patients who have an already compromised wound healing capacity.
Painful stimuli cause a diffuse adrenergic discharge leading to cutaneous vasoconstriction; thus, adequate pain control can improve cutaneous perfusion and potentially improve healing.
Major Trauma and Burns. Severe trauma and tissue loss affecting vital organs such as the brain, lungs, and abdominal viscera and major hemorrhage/ fluid loss from singular or multiple trauma or burn sites can require emergency surgical intervention and critical care. Hypovolemic shock as a consequence of circulatory volume loss, or compromised cardiac function due to chest trauma, needs vascular volume replacement and appropriate interventions to improve cardiac output and stop losses. The systemic inflammatory response syndrome that occurs in major trauma states is characterized by elevation of circulating cytokines and inflammatory mediators, including tumor necrosis factor-␣, resulting in activation and consumption of clotting factors and platelets potentially leading to clotting anomalies, disseminated intravascular coagulation (DIC), and subsequent delays in wound healing (65) . The infusion of large volumes of packed red cells also will affect coagulation largely by dilutional effects, as will cold intravenous fluid replacement (66) . The development of a posttraumatic immunoparalysis has implications in developing sepsis and subsequent delays in wound healing. Maintenance of a normovolemic state and body temperature together with good analgesia will facilitate adequate peripheral perfusion to soft tissue injuries. As with any traumatic wound, thorough wound inspection and cleansing are mandatory to assess wound severity, remove necrotic and nonviable tissue, and decrease the bacterial contamination. The magnitude of the local inflammatory response will depend on the severity of the injury (67) .
The presence of excessive wound contamination prolongs the inflammatory phase of healing, with persistence of neutrophils and continued release of ROS, with the potential for further tissue injury. Wound contamination in association with tissue hypoxia potentially suppresses macrophage-regulated fibroblast proliferation (68) . Deep soft tissue burns in particular elicit a major and often prolonged local inflammatory response associated with local tissue ischemia, thrombosis, and an intense vasoconstriction resistant to the effects of NO (69) .
ROS have been implicated in the impaired healing response associated with tissue ischemia (70) . There is evidence that peripheral vasoconstriction persists for up to 60 hrs following hypovolemia despite adequate resuscitation and a normal mean arterial pressure (71) . Mild or moderate anemia does not appear to deleteriously affect healing in a wellperfused wound, with collagen deposition being proportional to wound tissue oxygenation and perfusion (72) . The reperfusion of injured tissue itself can be deleterious to wound healing, with release of anaerobic metabolites and ROS creating additional oxidative stresses. Fat emboli and DIC following severe trauma can cause respiratory complications and occlusion of both larger and smaller cutaneous vessels causing general and focal tissue hypoxia and multiple-organ dysfunction syndrome (73, 74) .
Sepsis. Infection can be local or systemic. Local wound infection affects healing by prolonging the inflammatory phase. The local inflammatory response to soft tissue injury can be modified by systemic inflammatory changes, thus potentially masking the clinical signs of local wound infection. In critical illness, both a compromised innate immune defense and reduced adaptive immune response, as observed in posttraumatic immunosuppression, will predispose the patient to local and systemic infection. Sepsis-associated mortality rate in an intensive care setting remains high. The endotoxin-related excessive secretion of proinflammatory mediators, particularly tumor necrosis factor-␣, interleukins 1 and 6, and ␥-interferon from macrophages, is believed to be important in the development of whole body inflammation and septic shock. Systemic inflammation in sepsis appears to have a biphasic pattern, however, which includes a hypoinflammatory state associated with immunodeficiency characterized by monocyte deactivation and immunoparalysis (75) . A compromised leukocytic activity and deranged inflammatory response will have inhibitory effects on wound healing (76) . Septicemia can have profound effects on coagulation. Activation of the clotting cascade, via plasma and endothelial related inflammatory changes, can lead to DIC with a profound decrease in platelets and loss of a functional, organized clotting system. DIC in sepsis, as in major trauma, is associated with microcirculatory clot formation with potentially widespread effects on tissue perfusion not only in the soft tissues but also in major organs leading to multiple-organ failure (77) . These factors will compromise hemostasis and therefore healing. The systemic inflammatory responses in sepsis affect plasma viscosity and rheologic characteristics (78) . This may have important implications in tissue perfusion, particularly in situations where the capillary blood velocities are reduced. Hypothermia, potentially made worse by the infusion of cold intravenous fluid and fresh frozen plasma (or an equivalent), will compromise clotting and healing. Attention to patient warming is essential in these situations.
Specific Organ Failure
Respiratory Failure. Adequate gaseous exchange is essential for all biological systems, including wound healing. Tissue hypoxia secondary to hypoxemia will have profound effects on healing at all levels. This will be discussed in more detail elsewhere in this supplement.
Hepatic Failure. Decreased clotting factors, low plasma proteins, decrease in bactericidal activity, and failure of glucose regulation can all contribute to soft tissue wound failure. The influence of an increased bilirubin alone is not clear, as it is often associated with comorbidities, although tumor necrosis factor-␣ and endotoxemia recently have been implicated in obstructive jaundice (79, 80) .
Renal Failure. Acute or chronic renal impairment may require dialysis treatment. Raised uremic toxins and a metabolic acidosis will affect wound healing by influencing both the innate and adaptive immune systems. Hemo-and peritoneal dialysis are associated with increased susceptibility to infections. Down-regulation of circulating neutrophils due to their repeated activation triggering by dialysis membranes has been demonstrated. Circulating ROS also are increased as a result of dialysis membrane activation. Deficient responses of both B and T lymphocytes also are associated with renal dialysis (81) .
Gut Failure. A critically ill patient may have impaired gut absorption, either directly as a result of abdominal catastrophe or gastrointestinal surgery or indirectly as a result of dysfunctional bowel secondary to severe metabolic anomaly, trauma, or deinnervation causing a paralytic ileus. The enteral feeding of patients is preferred; parental feeding is given when the gut is unable to absorb sufficiently. Bacterial translocation of gut bacteria and toxins, including ROS, to the portal circulation can occur, causing sepsis and increased oxidative stress. The presence of higher levels of circulating ROS, including the superoxide radical (O 2 ·) and the hydroxyl radical (·OH), and impaired combating mechanisms have been implicated in impaired wound healing in ischemia-reperfusion injury and systemic inflammation via NO interaction and peroxynitrite (ONO 2 ·) production (82, 83) . The production of excessive amounts of ROS by neutrophils in prolonged inflammation can cause inactivation and depletion of wound antioxidants such as reduced glutathione and vitamins C and E (84) . An imbalance of ROS and antioxidants in wounds leads to cellular injury and extracellular matrix degradation by an excess in ROS (85, 86) .
Nutrition. Septic, surgical, and trauma patients in hypermetabolic states associated with the release of endogenous cytokines from activated leukocytes experience excessive protein loss in an effort to maintain normoglycemia and require additional caloric input to counter a negative nitrogen balance. Such patients consume body stores of fat and protein, particularly skeletal muscle, more rapidly than patients with normal metabolism. This, together with depletion of micronutrients and immunonutrients, has implications in immune system function and healing (87) . Elevated levels of steroids due to stress are intimately involved in muscle catabolism. Anabolic agents have been forwarded as possibly attenuating catabolism in trauma and sepsis. Insulin administration may help modulate muscle protein losses in patients with severe burns (88) . Growth hormone stimulates wound healing, but its effects in critical illness need further study (89) . Early nutritional assessment is therefore vital in the critically ill patient to prevent malnutrition (90) . The clinician, when presented with a critically ill patient with wounds and gut failure, needs to remember that parental feeding needs formulating with this in mind. Glucose is the main fuel for wound repair. Protein malnutrition and particularly deficiencies in the amino acids arginine and methiodine are associated with compromised wound healing due to prolonged inflammation and disruption of matrix deposition, cellular proliferation, and angiogenesis (91, 92) . Malnutrition is associated with decreased deposition of collagen in skin wounds (93) . Glutamine has been reported to enhance the actions of lymphocytes, macrophages, and, in particular, neutrophils and may be of particular benefit in severe infection and trauma (94) .
Glycine has inhibitory effects on leukocytes and may have an important role in reducing inflammation-related tissue injury (95) . Micronutrients such as vitamins and minerals are critically important in immune function and wound healing. Many trace metals, including manganese, magnesium, copper, calcium, and iron, are cofactors in collagen production and deficiencies influence its synthesis (91) . Zinc influences re-epithelialization and collagen deposition (96) . Zinc also has been demonstrated to greatly influence B and T lymphocyte activity, but many other nutrients including copper, selenium, several other metals, and several vitamins including A, B, C, and E have been implicated in immune dysfunction (97) . Vitamin C is the main vitamin associated with poor healing due to its influence on collagen modification (91) . L-arginine is required in a variety of metabolic functions, wound healing, and endothelial function. It is important in the synthesis of nitric oxide, and deficiency is linked to immune dysfunction and failure of wound repair. Maintenance of plasma oncotic pressure is dependent on adequate production of plasma proteins and is important in maintaining body water distribution and preventing soft tissue edema. Vitamins and minerals are essential for wound repair, particularly ascorbic acid, zinc, and selenium. Copper recently has been linked to vascular endothelial growth factor production (98) .
Pressure Ulcers. One of the most obvious consequences of poor soft tissue healing in the intensive care unit is the development of pressure ulceration. Prolonged localized pressure at the points of contact between external surfaces and the patient's bone prominences produces ischemia of the tissues sandwiched between them (99) . Raised tissue pressure induces increased capillary closure through its effect on critical closing pressures. Compromised cellular function due to prolonged, severe hypoxia may rapidly progress to cell death, with necrosis of skin, adipose tissue, and muscle, thus precipitating ulceration and further contributing locally to impaired healing (Fig. 3) . In critical illness, additional risk factors including depletion of soft tissue adipose and protein components, and tissue edema due to lowered plasma oncotic pressures, a leaky endothelium, and a potentially compromised peripheral perfusion may further compromise tissue perfusion by raising interstitial pressures.
Age, emergency admission to the intensive care unit, days in bed, and nutrition have been identified as risk factors for intensive care unit patients (100) . The same contributory factors will then hinder the healing of such injuries, resulting in a protracted and costly outcome. Increased awareness of pressure sores has meant that pressure-controlling mattresses and the frequent turning of patients are now used to reduce both the degree of focal pressure and its duration.
Invasive Procedures. The skin's innate immunity, including the presence of an acid environment and commensal microorganisms, is likely to be compromised in severe illness, due to alterations in body metabolism, skin perfusion, and the widespread use of antimicrobials. The presence of persistent foreign material, usually in the form of cannulas, breaching the epidermal protection afforded by skin, is an obvious portal of entry for microorganisms, particularly in this vulnerable patient group, with potential for local and systemic sepsis (101) . Devices breaching the skin and left in situ in soft tissues will cause a prolonged inflammatory response due to persistent leukocyte activation. The presence of a foreign body within the vascular lumen will stimulate platelet aggregation and thrombus formation. Inflammation of the adjacent vessel wall may cause an endothelial reaction sufficient to promote local thrombosis and even vessel occlusion, particularly when venous blood flow is sluggish. This is not infrequently associated with intravenous cannulation. Venous thrombosis precipitates local soft tissue edema by raising venous pressures and precipitating an inflammatory response. This can further compromise perfusion and wound healing. Central vein catheterrelated thrombosis is associated with catheter-related sepsis in intensive care unit patients (102) .
Postoperative Soft Tissue Wound Repair. Postoperative wounds, particularly those under particularly high tension, are more prone to dehiscence in a critically ill patient for many reasons. A typical and important example of this is the laparot- omy wound. Dehiscence is associated with major morbidity and mortality. Inclusion of a mesh or leaving the incision at least partly open will reduce tension on the wound, improve perfusion at the wound edges, and reduce the intraabdominal pressures. This technique is gaining wider acceptance, particularly as the quality of synthetic mesh continues to improve (103, 104) . The aim of wound closure is to restore continuity of the tissues with a minimum of morbidity. The clinician should be aware that the chosen wound closure technique should not subject the wound edges to excessive tension and that raised pressures between opposing sutures may lead to excessive capillary closure and tissue ischemia. The surgeon should aim to oppose and not necrose. The careful apposition of the incised tissue edges, avoiding any excessive tension, will help reduce wound edge ischemia, facilitate normal healing, and reduce the likelihood of wound dehiscence.
Excessive abdominal fluid collection and distended bowel due to inflammation, excessive lumen gas, and fluid accumulation secondary to an ileus frequently are seen in critical illness. This can lead to raised intra-abdominal pressures and development of an abdominal compartment syndrome, the abdomen becoming rigidly distended resulting in a sharp increase in intra-abdominal pressures, potentially above 40 mm Hg. This reduces the perfusion of intra-and extraperitoneal organs and laparotomy wounds, with potentially serious implications (105) . Respiratory function also can be compromised, as stenting of the diaphragm may cause basal atelectasis and require raised ventilatory pressures to maintain adequate gaseous exchange (106) . The exposure of the major vessels to excessive extrinsic pressures, particularly the major veins, affects limb perfusion and particularly venous drainage, resulting in limb edema and ischemia. Thus, the presence of a raised abdominal pressure, by compromising major organ function and limb perfusion, can affect many aspects of soft tissue wound healing regardless of wound location.
Drug Therapies in Critical Illness. The complexity of wound healing makes it vulnerable to disruption by a variety of drug therapies. In the setting of critical illness, there are drug therapies that have particular interest from a wound healing standpoint. These include vasoactive agents, anti-inflammatories, both steroidal and nonsteroidal, and sedative agents. The widespread and prolonged use of antibiotics may predispose the patient to develop multiply resistant strains of bacteria and pseudomembranous colitis. Therefore, frequent and thorough microbiological assessment is essential to afford better use of antimicrobial agents. Critically ill patients will be more vulnerable to wound infection, so particular attention to wound care and aseptic techniques is required.
The increasing use of steroids to achieve supraphysiologic levels in the treatment of inflammatory, immune, and neoplastic conditions means that patients with critical illnesses are more likely to receive steroid medication.
Anti-inflammatory agents have the potential to influence the inflammatory phase of healing, with knock-on effects on proliferation and re-epithelialization. There is ample evidence that exogenous steroids can inhibit tissue repair. More recent evidence suggests that glucocorticoids regulate gene expression during the healing of cutaneous wounds, various cytokines, growth factors, and nitric oxide enzymes being targets (107) . The steroidrelated down-regulation of protein production also has nutritional implications for critically ill patients in catabolic states. Steroids have been proposed as therapeutic adjuvants in systemic inflammation by protecting the host against neutrophil-mediated injury and reducing leukocyte migration to inflammatory sites (108) .
In prescribing nonsteroidal antiinflammatories as analgesics, particularly after surgery, the clinician is not routinely concerned with their effects on healing. The potentially detrimental effects of nonsteroidal anti-inflammatories may gain greater significance in critically ill patients with soft tissue wounds. The negative influence of nonsteroidal antiinflammatories on the healing of skin wounds has been demonstrated (109) .
Many studies have demonstrated that anti-inflammatories decrease collagen production and neovascularization (110, 111) . Vasopressor agents are important in the management of shock, particularly severe distributive shock, caused by a generalized NO-induced vasodilation typically seen in sepsis, pancreatitis, and severe burns. They are used in combination with fluid replacement to increase the mean arterial pressure and sustain cardiac and cerebral perfusion. Agents such as norepinephrine increase peripheral vasomotor tone via ␣-adrenergic receptors, reducing perfusion, potentially inducing peripheral ischemia, and influencing soft tissue healing. The administration of alternative agents such as vasopressin and corticosteroids in septic shock is less likely to cause soft tissue ischemia because they act via nonadrenergic mechanisms (112) . In common with several anesthetic and sedative agents used in the intensive care setting, propofol can profoundly decrease blood pressures in a hypovolemic patient, and therefore correction of hypovolemia is essential before administration (113) . The local anesthetic agents lidocaine and procaine, particularly in combination with adrenaline, in operative wound infiltration, have been demonstrated to impair wound healing (114, 115) . Clinicians should always be mindful of the requirements of healing when choosing the treatment regimens for a patient who has the added burden of a significant soft tissue wound. 
